New advances in the improvement of the design of drugs against glial globular tauopathy
José Antonio del Río, principal investigator at the Institute for Bioengineering of Catalonia (IBEC) together with Dr. Isidre Ferrer from Bellvitge Biomedical Research Institute (IDIBELL) led a study where they have unraveled that the pathology shown by patients with Globular Glial Tauopathy is due to the generation of harmful protein deposits for neurons and glial cells.
Tauopathies are characterized by the accumulation of phosphorylated tau protein, that associates with phosphate groups.
José Antonio del Río, principal investigator at the Institute for Bioengineering of Catalonia (IBEC) together with Dr. Isidre Ferrer from Bellvitge Biomedical Research Institute (IDIBELL) led a study where they have unraveled that the pathology shown by patients with Globular Glial Tauopathy is due to the generation of harmful protein deposits for neurons and glial cells.

Application Deadline: 14/02/2020
The institute for Bioengineering of Catalonia (IBEC) and the Institute for Complex Molecular Systems (ICMS), a research institute of the Eindhoven University of Technology (TU/e), have signed the first agreement between the two institutes to foster their collaboration. Both research centres share similarities such as their multidisciplinarity, their active missions to connect with industry and clinicians, and a strong research in nanomedicine, chemical biology, chip technology, regenerative medicine and tissue engineering. This institutional alliance will allow to share resources, knowledge and provide mobility programs. 
Application Deadline: 31/01/2020